Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple‐Negative Breast Cancer
Advanced Science · 2024-09 · 11 (36)
DOI: 10.1002/advs.202309903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 29.07.2024. Verfasst von Wenwen Tian und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guan…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Autophagy, Disease Progression. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aggressive triple‐negative breast cancer (TNBC) still lacks approved targeted therapies, requiring more exploration of its underlying mechanisms. Previous studies have suggested a potential role of SAT1 (Spermidine/Spermine N1‐acetyltransferase 1) in cancer, which needs to be further elucidated in breast cancer. In this study, highly expressed SAT1 in TNBC signified worse patient prognoses. And SAT1 knockdown effectively inhibited the proliferation and migration abilities of TNBC cells in vitro and in vivo. In terms of mechanism, the transcription factor JUN enhanced SAT1 transcriptional activity by binding to its promoter region. Then, SAT1 protein in the cytoplasm engaged in directly binding with YBX1 for sustaining YBX1 protein stability via deubiquitylation mediated by the E3 ligase HERC5. Further, SAT1 was found to suppress autophagy remarkably via stabilization of mTOR mRNA with the accumulation of YBX1‐mediated methyl‐5‐cytosine (m5C) modification. These findings proved that SAT1 drives TNBC progression through the SAT1/YBX1/mTOR axis, which may provide a potential candidate for targeted therapy in advanced TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
- Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, 510095, P. R. China.
- The First People's Hospital of Foshan, Foshan, 528000, P. R. China.
- The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, P. R. China.
ORCID-Profile: Wenwen Tian
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Tian, W., Zhu, L., Luo, Y., Tang, Y., Tan, Q., Zou, Y., Chen, K., Deng, X., Tang, H., Li, H., Cai, M., Xie, X., & Ye, F. (2024). Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple‐Negative Breast Cancer. Advanced Science, 11(36). https://doi.org/10.1002/advs.202309903
Vancouver
Tian W, Zhu L, Luo Y, Tang Y, Tan Q, Zou Y, et al. Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple‐Negative Breast Cancer. Advanced Science. 2024;11(36). doi:10.1002/advs.202309903
BibTeX
@article{Tian2024,
author = {Tian, Wenwen and Zhu, Lewei and Luo, Yongzhou and Tang, Yuhui and Tan, Qingjian and Zou, Yutian and Chen, Kun and Deng, Xinpei and Tang, Hailin and Li, Hongsheng and Cai, Manbo and Xie, Xiaoming and Ye, Feng},
title = {Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple‐Negative Breast Cancer},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {36},
doi = {10.1002/advs.202309903}
}
EUVIMED